Add to ORKGImpressive advances in medicine and technology have boosted health and extended life expectancy - but not for everyone. Vital new medicines for diseases such as HIV/AIDS are priced out of reach of the millions of sick people in the developing world, in part due to global patent rules which restrict the availability of affordable generic versions of patented medicines. In 2001, all members of the World Trade Organization adopted the 'Doha Declaration', promising to prioritize public health over private patent rights and to promote 'access to medicines for all'. This paper examines how the government of the United States is contravening this commitment by using technical assistance, bilateral and regional trade agreements, and the threat of t...
Each year, 11 million people die from infectious diseases, many of them because they cannot afford b...
Drug prices are uniquely susceptible to radical price reductions through generic competition. Patent...
Over the past fifteen years, the United States and other developed countries have employed trade agr...
This paper shows how new global patent rules, introduced by the World Trade Organisation, will raise...
Despite HIV becoming a manageable illness due to advancements in pharmaceuticals, over a million peo...
Is access to medicines at risk despite the Doha Declaration? What are the alternative mechanisms tha...
Five years ago, members of the World Trade Organisation (WTO) signed a ministerial agreement to ensu...
Perhaps the most compelling Grand Challenge in healthcare is addressing diseases that primarily affl...
181-189Many scholars argued that improving access to medicine requires major amendments to the paten...
While the recent WTO agreement allowing developing countries to import life-saving drugs by bypassin...
The forthcoming WTO summit offers an unparalleled opportunity to change global patent rules, known a...
This article critically analyzes the agreement implementing Paragraph 6 of the Doha Declaration. The...
In response to concerns that patent protection for pharmaceuticals negatively affected world health,...
Over the past fifteen years, the United States and other developed countries have employed trade agr...
Who invents medicines for the poor of the world? This question becomes very important where the WTO ...
Each year, 11 million people die from infectious diseases, many of them because they cannot afford b...
Drug prices are uniquely susceptible to radical price reductions through generic competition. Patent...
Over the past fifteen years, the United States and other developed countries have employed trade agr...
This paper shows how new global patent rules, introduced by the World Trade Organisation, will raise...
Despite HIV becoming a manageable illness due to advancements in pharmaceuticals, over a million peo...
Is access to medicines at risk despite the Doha Declaration? What are the alternative mechanisms tha...
Five years ago, members of the World Trade Organisation (WTO) signed a ministerial agreement to ensu...
Perhaps the most compelling Grand Challenge in healthcare is addressing diseases that primarily affl...
181-189Many scholars argued that improving access to medicine requires major amendments to the paten...
While the recent WTO agreement allowing developing countries to import life-saving drugs by bypassin...
The forthcoming WTO summit offers an unparalleled opportunity to change global patent rules, known a...
This article critically analyzes the agreement implementing Paragraph 6 of the Doha Declaration. The...
In response to concerns that patent protection for pharmaceuticals negatively affected world health,...
Over the past fifteen years, the United States and other developed countries have employed trade agr...
Who invents medicines for the poor of the world? This question becomes very important where the WTO ...
Each year, 11 million people die from infectious diseases, many of them because they cannot afford b...
Drug prices are uniquely susceptible to radical price reductions through generic competition. Patent...
Over the past fifteen years, the United States and other developed countries have employed trade agr...